It is of clinical interest to decompose a three material mixture into its constituted substances using dual-energy CT. In radiation therapy, for example material decomposition can be used to determine tissue properties for the calculation of dose in treatment planning. Due to use of polychromatic spectrum in CT, beam hardening artifacts prevent to achieve fully satisfactory results. Here an iterative reconstruction algorithm proposed by A. Malusek, M. Magnusson, M.Sandborg, and G. Alm Carlsson in 2008 is implemented to achieve this goal. The iterative algorithm can be implemented with both single- and dual-energy CT. The material decomposition process is based on mass conservation and volume conservation assumptions. The implementation and evaluation of iterative reconstruction algorithm is done by using simulation studies of analyzing mixtures of water, protein and adipose tissue. The results demonstrated that beam hardening artifacts are effectively removed and accurate estimation of mass fractions of each base material can be achieved with the proposed method. We also compared our novel iterative reconstruction algorithm to the commonly used water pre-correction method. Experimental results show that our novel iterative algorithm is more accurate.

No description available.

Unsicherheiten in der Reichweitevorhersage limitieren wesentlich das Ausnutzen der Vorteile von Protonentherapie gegenüber konventioneller Strahlentherapie. Die Verwendung von Zwei-Spektren-Computertomographie (DECT) zur direkten Vorhersage des Bremsvermögen (DirectSPR) ermöglicht eine relevante Verbesserung der Reichweitevorhersage gegenüber der üblicherweise verwendeten Ein-Spektren-Computertomographie (SECT). Im Rahmen dieser Dissertation wurde die Variation in der Reichweitevorhersage zwischen 17 europäischen Partikeltherapiezentren experimentell verglichen. Die Genauigkeit der Reichweitevorhersage bei Verwendung einer DirectSPR-Implementierung wurde umfassend quantifiziert und die Implementierung in die klinische Routine integriert. Dies führte zu einer Reduzierung des klinischen Sicherheitssaum um ca. 35% für die Behandlung von quasistatischen Tumoren in Kopf und Becken und damit einer Schonung des Normalgewebes sowie der das Zielgebiet umgebenden Risikoorgane. Darüber hinaus wurde die DirectSPR-Implementierung zur Bestimmung von Gewebeparametern sowie deren Variabilität für zehn Organe im Kopf und Becken in einer Patienkohorte genutzt. Die vorgestellten Ergebnisse etablieren DECT weiter als zukünftiges Standard-Bildgebungsverfahren in der Partikeltherapie.:1. Introduction 2. Proton therapy 2.1. Physical principles of proton therapy 2.2. Treatment with protons 2.3. Accuracy in proton therapy 3. CT Imaging for proton therapy 3.1. Principles of CT imaging 3.2. CT-based range prediction 3.3. Investigated phantoms and materials 3.4. DECT scan acquisition 3.5. Determination of proton stopping power for reference materials 4. Accuracy of stopping-power prediction in European proton centres 4.1. Study design 4.2. Experimental setup and analysis 4.3. Results 4.4. Discussion of determined deviations 4.5. Conclusion and outlook 4.6. Establishment of guidelines for HLUT calibration 5. Range uncertainties in DirectSPR-based treatment planning 5.1. Clinical implementation of DirectSPR 5.2. Uncertainty quantification 5.3. Resulting uncertainties in SPR prediction 5.4. Experimental validation 5.5. Dosimetric effect of range uncertainty reduction 5.6. Discussion 6. In-vivo tissue characterisation using DirectSPR 6.1. Tissue parameter determination by Woodard and White 6.2. Data preparation and analysis 6.3. Determined tissue parameters and variations 6.4. Discussion 7. The future of image-based range prediction 7.1. Particle imaging 7.2. Creation of synthetic CT images 7.3. Photon-counting computed tomography 8. Summary 9. Zusammenfassung A. Supplement A.1. Investigated materials A.2. EPTN study: Individual results A.3. DirectSPR validation results / Imaging-related range uncertainties effectively limit the full exploitation of the benefits proton therapy offers with respect to conventional photon radiotherapy. The use of dual-energy computed tomography (DECT) for direct stopping-power prediction (DirectSPR) was determined to provide relevant improvements in range prediction over commonly used singleenergy CT (SECT). Within this thesis, the variation in range prediction accuracy between 17 European particle treatment centres were experimentally quantified to determine the current status quo in the community. The overall range uncertainty when using a DirectSPR implementation in treatment planning was comprehensively quantified and the implementation integrated into the clinical workflow. This led to a reduction of clinical safety margins by about 35% for the treatment of quasi-static tumours in the head and pelvis, effectively reducing the dose to surrounding healthy tissue and organs at risk. The DirectSPR implementation was furthermore utilised to assess tissue parameters and their inter- and intra-patient variability for ten organs in the head and pelvis from a cohort of patients. The presented results further establish DirectSPR as the future standard imaging modality in particle therapy.:1. Introduction 2. Proton therapy 2.1. Physical principles of proton therapy 2.2. Treatment with protons 2.3. Accuracy in proton therapy 3. CT Imaging for proton therapy 3.1. Principles of CT imaging 3.2. CT-based range prediction 3.3. Investigated phantoms and materials 3.4. DECT scan acquisition 3.5. Determination of proton stopping power for reference materials 4. Accuracy of stopping-power prediction in European proton centres 4.1. Study design 4.2. Experimental setup and analysis 4.3. Results 4.4. Discussion of determined deviations 4.5. Conclusion and outlook 4.6. Establishment of guidelines for HLUT calibration 5. Range uncertainties in DirectSPR-based treatment planning 5.1. Clinical implementation of DirectSPR 5.2. Uncertainty quantification 5.3. Resulting uncertainties in SPR prediction 5.4. Experimental validation 5.5. Dosimetric effect of range uncertainty reduction 5.6. Discussion 6. In-vivo tissue characterisation using DirectSPR 6.1. Tissue parameter determination by Woodard and White 6.2. Data preparation and analysis 6.3. Determined tissue parameters and variations 6.4. Discussion 7. The future of image-based range prediction 7.1. Particle imaging 7.2. Creation of synthetic CT images 7.3. Photon-counting computed tomography 8. Summary 9. Zusammenfassung A. Supplement A.1. Investigated materials A.2. EPTN study: Individual results A.3. DirectSPR validation results

International Society for Clinical Densitometry (ISCD) rekommenderar att precisionsbestämning av bentäthetsmätning görs på varje klinik för att bedöma reproducerbarheten. Bentäthetsmätning görs för att diagnosticera osteoporos, följa upp behandling och förutsäga frakturrisk. I studien användes Dual energy x-ray absorptiometry (DXA) för att utföra dubbla mätningar på redan inbokade patienter på klinisk fysiologi, Skånes Universitetssjukhus (SUS), Lund. 105 patienter ingick i studien. Mätningarna utfördes på helkropp, totalhöft, lårbenshals och ländrygg. Helkroppsmätningar ingick i en interindividuell studie och de övriga ingick i intraindividuella studier. Reproducerbarheten uttrycktes som minsta signifikanta skillnaden (LSC), root mean square standardavvikelse (RMS SD) och variationskoefficient (%CV). Reproducerbarheten i studien var god med låga värden för LSC och RMS SD. %CV understeg de av ISCD rekommenderade maxvärdena, vilka är 1,8 % för totalhöft, 2,5 % för lårbenshals och 1,9 % för ländrygg. / It is recommended by the International Society for Clinical Densitometry (ISCD) that every clinic performs a precision assessment of bone densitometry to evaluate the reproducibility. Bone densitometry is used for diagnosis of osteoporosis, to monitor response to treatment and to assess patients’ risk of fractures. Dual energy x-ray absorptiometry (DXA) was used to perform double scans of patients already booked for examination at the section of clinical physiology, Skåne University Hospital (SUS), Lund. 105 patients were included in the study. Measurements were made at whole body, total hip, femoral neck and lumbar spine. The whole body scans were included in an interindividual study, whereas the others were included in intraindividual studies. The reproducibility was expressed as least significant change (LSC), root mean square standard deviation (RMS SD) and coefficient of variation (%CV). The reproducibility in the study was good, with low values for LSC and RMS SD. %CV fell below the maximal values recommended by the ISCD, which are 1,8 % for total hip, 2,5 % for femoral neck and 1,9 % for lumbar spine.

Selective Serotonin Reuptake Inhibitors and Bone mineral Density in a Population of U.S. Premenopausal Women May 2011 M.S., UNIVERSITY of Massachusetts Amherst Directed by: Professor Elizabeth R. Bertone-Johnson Low bone mineral density (BMD) in post-menopausal women is a risk factor for bone fractures and osteoporosis development. Prior studies in post-menopausal women have shown the use of antidepressant medications, specifically selective serotonin reuptake inhibitors (SSRIs) to be inversely related to BMD. However, the association has not been studied in pre-menopausal women. Current SSRI use is widespread with 8% of U.S. women age 18-44 reporting use. We evaluated the association between SSRIs and BMD and bone mineral content (BMC) cross-sectionally using data from the University of Massachusetts Vitamin D Status Study. SSRI use, diet, and lifestyle factors were assessed by questionnaire. BMD and BMC were measured using dual-energy x-ray absorptiometry (DEXA). The study included 256 women aged 18-30 (mean=21.6 years, SD=4.3 years). In this population, SSRI use was 5%, BMD values ranged from 0.97-1.38 g/cm2 (mean 1.16, SD 0.08), and BMC values ranged from 1833g to 3682g (mean 2541.5, SD=349.2). After adjustment for age, body mass index, and physical activity, mean BMD in the 13 users of SSRIs was 1.15g/cm2 (SD=0.06) compared to 1.16g/cm2 (SD=0.77) in the 243 non-users (p =0.66). After the same adjustments, mean BMC in the 13 users was 2467.1g (SD=285.0) compared to 2547.6g (SD=352.6) in the 243 non-users (p=0.94). Our findings do not support an inverse association between SSRI use and BMD or BMC. However, given the prevalence of SSRI use in young women and the potential for adverse effects on bone health, further study of this association is warranted.

No description available.

No description available.

Övervikt och fetma hos barn och ungdomar har blivit allt mer förekommande och prevalensen ökar dramatiskt över hela världen. Sedan raffinerade kolhydrater introducerades har även kariessjukdomen fått större utbredning. Då det finns gemensamma bakomliggande faktorer som påverkar både vikt och kariesprevalens vill vi i vår litteraturstudie undersöka om det finns något samband mellan body mass index (BMI) och kariesprevalens för barn och ungdomar. Efter sökningar i den medicinska databasen PubMed på artiklar från de senaste 5 åren fann vi oeniga resultat med jämn fördelning. Resultatet av litteraturstudien är att två av de undersökta studierna tyder på att det inte finns något samband mellan BMI och kariesprevalens, lika många anser att det finns en svag eller möjlig association, medan två studier ansåg att det fanns ett signifikant samband. Majoriteten av de undersökta studierna kan alltså inte se något signifikant samband mellan BMI och kariesprevalens. För att säkerställa ett samband eller ej krävs fler studier och en djupare analys av tillförlitligheten i respektive studie.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.

Contexte : Le cancer du sein est le cancer le plus fréquent et le deuxième cancer le plus mortel chez la femme. Les techniques d'imagerie constituent un élément essentiel pour le dépistage, le diagnostic, la stadification et le traitement du cancer du sein. L'imagerie par résonance magnétique avec injection de produit de contraste (CE-MRI) est actuellement la technique d'imagerie standard pour la détection du développement vasculaire anormal et des prises de contraste des lésions mammaires. CE-MRI est cependant très coûteuse et peu disponible. De plus, sa résolution spatiale pourrait être insuffisante pour la détection de certains types de lésions, et ne permet pas d'imager les amas de microcalcifications. Le développement de l'angiomammographie double-énergie (CESM) a permis l'utilisation des produits de contraste intraveineux en clinique avec des appareils conventionnels de mammographie. Cependant, CESM est une technique de projection 2D et présente, par conséquence, des limites pour décrire la structure 3D interne des lésions et pour fournir une information fonctionnelle 3D précise.La tomosynthèse numérique du sein avec injection de produit de contraste (CE-DBT) et le scanner dédié du sein avec injection de produit de contraste (CE-bCT) sont deux techniques d'imagerie actuellement en investigation par des groupes de recherche académiques et industriels. Il est cependant anticipé que le potentiel quantitatif de la CE-DBT soit limité, en raison de la faible résolution en profondeur due à l'ouverture angulaire limitée de la DBT. CE-bCT, avec sa résolution spatiale quasi-isotrope et son intensité de signal proportionnelle au coefficient d'atténuation linéaire, est supposée offrir une information quantitative plus précise, bien qu'une utilisation à faible dose de radiation reste toujours un défi.Objectifs : L'objectif de cette thèse a été d'étudier la faisabilité de la méthode CE-bCT et sa capacité à détecter et localiser des tumeurs vascularisées, ainsi que d'offrir de l'information morphologique et fonctionnelle précise sur les tumeurs. Pour comprendre la valeur ajoutée de la CE-bCT par rapport à CE-DBT, le potentiel quantitatif des deux méthodes a également été comparé. Nos études ont été réalisées grâce à des simulations par ordinateur, validées par des mesures expérimentales.Méthodes : Dans un premier temps, une plateforme de simulation capable de modéliser différentes techniques d'imagerie du sein par rayons X, et fournissant des images radiographiques de fantômes numériques simples et complexes, a été implémentée et validée. Deuxièmement, une étude d'optimisation pour la technique CE-bCT basée sur une approche double-énergie a été réalisée, dans le but de maximiser la qualité des images équivalentes-iode ainsi que des images morphologiques. Enfin, le potentiel quantitatif des méthodes CE-bCT et CE-DBT a été comparé au travers de l'évaluation de la détectabilité, de la caractérisation, de la localisation et de la mesure de l'étendue 3D des lésions iodées. Dans une étude impliquant des observateurs humains, la détectabilité et la caractérisation des lésions iodées de différentes tailles, formes et concentrations ont été comparées entre CE-bCT et CE-DBT, grâce à l'utilisation d'un fantôme anthropomorphique numérique du sein.Conclusions : Les études de simulation menées pendant cette thèse suggèrent que le scanner dédié du sein avec injection de produit de contraste iodé pourrait être une technique réalisable pour la détection, localisation et caractérisation des tumeurs du sein, pour un niveau de dose comparable à une mammographie standard. Bien que les comparaisons préliminaires avec CE-DBT suggèrent une performance comparable sur la détection et caractérisation, l'information 3D complète combinée avec une haute résolution spatiale font de CE-bCT une évolution intéressante de CESM vers une évaluation quantitative 3D des prises de contraste, et une alternative potentielle à CE-MRI pour certaines indications cliniques. / Background: Worldwide, breast cancer is the most common cancer and second deadliest cancer in women. Diagnostic imaging techniques are a critical part for screening, diagnosis, tumor staging and cancer therapy of the breast. Contrast-Enhanced Magnetic Resonance Imaging (CE-MRI) is the current standard imaging technique allowing detection of abnormal vascular development and lesion contrast uptake. CE-MRI is however very costly and not widely available. Moreover, its spatial resolution might not be sufficient to depict certain types of lesions including microcalcifications. The development of Contrast-Enhanced Spectral Mammography (CESM) has made the clinical use of intravenous contrast enhancement with conventional mammography possible. However, CESM is a 2D projection technique and therefore presents limitations to depict the 3D internal structures of lesions and to provide accurate quantitative 3D functional information.Contrast-Enhanced Digital Breast Tomosynthesis (CE-DBT) and dedicated Contrast-Enhanced Breast CT (CE-bCT) are two breast imaging modalities currently under investigation by academic and industrial research groups. It is however anticipated that the quantitative potential of CE-DBT is limited, due to the inherent low depth-resolution of limited opening angle DBT modality. CE-bCT with quasi-isotropic spatial resolution and voxel signal intensity proportional to the linear attenuation coefficient is believed to offer more accurate quantitative information, though a low-dose operation is still a challenge.Objectives: The purpose of this thesis has been to study the technical feasibility of CE-bCT and its potential to accurately depict and localize tumors, as well as to provide accurate quantitative morphological and functional imaging information about tumors, at low radiation dose levels. To understand the incremental value of CE-bCT over CE-DBT, the quantitative potential of both technologies have been compared. This investigation has been performed through computer simulations.Methods: At first, a simulation platform capable of modeling various X-ray breast imaging techniques and providing radiographic images of simple and complex computational phantoms was developed and validated. Secondly, an optimization study of a CE-bCT technique based on a dual-energy approach was performed, aiming to maximize image quality of iodine-enhanced and morphological images. Finally, the quantitative potential of CE-bCT and CE-DBT was compared through the assessment of iodine-enhanced lesion detectability, characterization, localization and 3D extent measurement. In a human observer study, depiction and characterization of iodine-enhanced lesions of different sizes, shapes and iodine uptakes was compared between CE-bCT and CE-DBT using a mesh-based anthropomorphic breast phantom.Conclusions: The simulation studies in this PhD thesis suggest that dual-energy iodine-injected CE-bCT could be a feasible technique for breast tumor depiction, localization and characterization, with dose levels comparable to standard mammography. While preliminary comparisons with CE-DBT suggests comparable depiction and characterization performance, the fully 3D information combined with high spatial resolution confirms CE-bCT as an interesting low-dose evolution of CESM toward 3D quantitative assessment of contrast uptakes and potential alternative to